ID: MRFR/LS/5337-HCR | February 2021 | Region: Global | 90 pages
The cell harvesting market is expected to grow significantly over the forecast period. It is estimated that the cell harvesting market is expected to register a CAGR of Approx. 12.60% with an estimated market value of USD 9.8 Billion during the forecast period from 2020 to 2027. Cell harvesting is performed by separating the cell culture from the growing medium, involving techniques such as centrifugation, microfiltration, and depth filtration.
Numerous factors such as an increase in chronic infections and diseases, the rapid growth of the biotechnology and pharmaceutical industries, and rising research in regenerative medicines are expected to drive the growth of the cell harvesting market. Moreover, the cost-effectiveness, ease of use, the durability of harvesters, technological advancements, and design development of cell harvester devices fuel the growth of the cell harvesting market. Several companies are also involved in new product launches to strengthen their position in the market. For instance, in September 2018, AVITA Medical, a global regenerative medicine company, announced that the US Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL Autologous Cell Harvesting Device (RECELL System). This device helps to treat severe burns in patients of 18 years and older.
ads-tec GmbH, Argos Technologies, Inc., Arthrex, Inc., Avita Medical, Bertin, connectorate, Cox Scientific, hynoDent AG, PerkinElmer Inc., Scinomix, Teleflex Incorporated, and TERUMO CORPORATION are some of the key players in the cell harvesting market.
However, the technical complexity of harvesters, coupled with ethical issues related to embryonic stem cell research may curb the growth of the cell harvesting market. Stringent government regulations and mandatory licensing rules may also hamper the market growth during the assessment period.
The cell harvesting market has been segmented into product type, application, and end user.
The cell harvesting market, on the basis of product type, has been segmented into manual cell harvesters and automated cell harvesters.
The manual cell harvesters segment is estimated to hold the largest share owing to the high preferability of manual cell harvesters, whereas the automated cell harvesters segment is expected to be the fastest growing segment due to increased awareness and rise in the use of automated technologies in devices.
The cell harvesting market, by application, has been segmented into biopharmaceutical application, stem cell research, and others.
The cell harvesting market, by end user, has been segmented into pharmaceutical companies, biotechnology companies, research institutes, and others.
The cell harvesting market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the cell harvesting market owing to a well-developed healthcare sector and growing healthcare expenditure. For instance, according to the data published by the Committee for a Responsible Federal Budget in May 2018, the US spent about USD 3.5 trillion, or 18% of its Gross Domestic Product (GDP) on health expenditures, which accounted for more than twice the average among developed countries in 2017. Additionally, many companies in this region focus on the innovation of new treatment options, thus being a lucrative option for the growth of the cell harvesting market in this region.
Europe is expected to hold the second largest position in the cell harvesting market. The market growth in this region owes to the availability of funds for research. For instance, according to the data published by the National Institute of Health Funding (NIHR) in 2016, funding of EUR 928 million was announced for new NIHR Biomedical Research Centers (BRC) and NIHR Clinical Research Facilities (CRF) for five years starting from April 2017.
Asia-Pacific is anticipated to be the fastest growing region in the cell harvesting market due to the presence of a huge patient population and continuously developing economies.
Cell Harvesting Market Share (%), by Region, 2017
Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)
On the other hand, the Middle East and Africa has the least share of the market. The majority of the market of this region is expected to be held by the Middle Eastern region due to growing government initiatives for the healthcare sector.
Cell Harvesting Market, by Product Type
Cell Harvesting Market, by End User
Cell Harvesting Market, by Region
The report for Cell Harvesting Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
|Market Size||2027: USD 9.8 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product Type, Application, and End user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Ads-tec GmbH, Argos Technologies, Inc., Arthrex, Inc., Avita Medical, Bertin, connectorate, Cox Scientific, hynoDent AG, PerkinElmer Inc., Scinomix, Teleflex Incorporated, and TERUMO CORPORATION|
|Key Market Opportunities||
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Cell harvesting is performed by separating the cell culture from the growing medium, involving techniques such as centrifugation, microfiltration, and depth filtration.
Centrifugation and microfiltration are two methods most commonly used for harvesting.
The cell harvesting market is predicted to touch USD 9.8 Billion by 2027.
The Americas is projected to command the largest share in the cell harvesting market.
Pharmaceutical companies will lead the cell harvesting market.
Mandatory licensing rules may limit market growth.
The cell harvesting market is projected to grow at an 12.60% CAGR between 2020-2027.